These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6133617)

  • 21. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
    Beasley CM; Dellva MA; Tamura RN; Morgenstern H; Glazer WM; Ferguson K; Tollefson GD
    Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of state-dependent reversal of tardive dyskinesia: phenomenological probe in humans.
    Goswami U; Narayanan HS; Channabasavanna SM
    J Clin Psychopharmacol; 1985 Feb; 5(1):48-50. PubMed ID: 2857733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical differences between metoclopramide- and antipsychotic-induced tardive dyskinesias.
    Lang AE
    Can J Neurol Sci; 1990 May; 17(2):137-9. PubMed ID: 1972649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models of tardive dyskinesia [proceedings].
    Davidson AB
    Psychopharmacol Bull; 1981 Jan; 17(1):45-7. PubMed ID: 7232657
    [No Abstract]   [Full Text] [Related]  

  • 26. Oral tardive dyskinesia in the rat.
    Sundén-Kuronen B; Pohto P; Alanen E
    Acta Odontol Scand; 1983 Dec; 41(6):343-8. PubMed ID: 6581673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MSH and MIF-I in animal models of tardive dyskinesia.
    Davis KL; Kastin AJ; Beilstein BA; Vento AL
    Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD; Eudicone JM; Pikalov A; Kim E
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
    Carlson KR; Eibergen RD
    Ann N Y Acad Sci; 1976; 281():336-49. PubMed ID: 828468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypersensitivity to apomorphine in rats treated with neuroleptics: a model of tardive dyskinesia].
    Gómez A; Troncoso San Martín E; Pesenti L
    Rev Med Chil; 1982 Apr; 110(4):319-22. PubMed ID: 6130590
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tardive dyskinesia: an increased risk of neuroleptics in elderly women].
    Jessurun AY; Stek ML
    Tijdschr Gerontol Geriatr; 1995 Oct; 26(5):197-9. PubMed ID: 8750979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An animal model to study the molecular basis of tardive dyskinesia.
    Bishnoi M; Boparai RK
    Methods Mol Biol; 2012; 829():193-201. PubMed ID: 22231815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of two iatrogenic dyskinesias.
    Karson CN; Jeste DV; LeWitt PA; Wyatt RJ
    Am J Psychiatry; 1983 Nov; 140(11):1504-6. PubMed ID: 6137963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials (author's transl)].
    Gaillard-Sizaret C; Gaillard P
    Therapie; 1979; 34(5):555-74. PubMed ID: 44767
    [No Abstract]   [Full Text] [Related]  

  • 39. ECT and tardive dyskinesia.
    Lerer B
    J Clin Psychiatry; 1984 Apr; 45(4):188. PubMed ID: 6715296
    [No Abstract]   [Full Text] [Related]  

  • 40. Tardive dyskinesia and second-generation antipsychotics.
    Ross DE
    Am J Psychiatry; 2005 Feb; 162(2):405; author reply 405-6. PubMed ID: 15677620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.